We are reporting a new case of lethal strongyloidiasis of an HIV-infec
ted patient. After discussion of the actual classification, dividing s
trongyloidiasis in an intestinal form, hyperinfestation and systemic s
trongyloidiasis, we try to apply this classification on the aquired im
munodeficiency syndrome by doing a review of the published cases so fa
r. This review shows the limits of the current classification. Treatem
ent actually consists of thiabenadazole or ivermectine, but survival i
s scarce. A systematic research of strongyloidiasis seems to be useful
in HIV-infected patients living or having lived in endemic aereas.